Anti-Cetuximab Polyclonal Antibody|抗西妥昔单抗多克隆抗体(靶标：西妥昔单抗（抗EGFR单抗）)
- 货号：RB9TAF004014
- 价格：面议
- 点击：197
产品介绍
产品参数
| 形态 | Liquid |
|---|---|
| 宿主种属 | Rabbit |
| 克隆性 | Polyclonal |
| 抗体亚型 | IgG |
| 纯化方式 | Purified by antigen affinity column. |
| 内毒素水平 | Please contact with the lab for this information. |
| 应用 | ELISA |
| 特异性 | The product is specific for Cetuximab. This antibody serves as an excellent positive control for Cetuximab immunogenicity (ADA) assays. |
| 靶标 | Rabbit polyclonal to Erbitux. |
| 免疫原 | Cetuximab |
| 储存缓冲液 | 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. |
| 稳定性和储存 | The product can be stored for 2 - 3 weeks at 2 to 8°C or for up to 12 months at -20°C. Avoid repeated freezing and thawing cycles. |
| 产品使用说明 | ELISA:1:5000-1:20000;IHC:1:50-1:500;WB:1:500-1:2000 |
| 登录号 | CAS: 205923-56-4 |
| 背景信息 | Cetuximab (Erbitux) is a chimeric (mouse/human) monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer. Cetuximab, as an epidermal growth factor receptor (EGFR) inhibitor, binds to EGFR. • Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies., PMID:36408164 • Polyclonal antitumor immunoglobulin may play a role in ovarian cancer adjuvant therapy., PMID:21255939 |
| 备注 | For research use only. |
相关产品:
| 产品名称 | 点击数 |
|---|---|
| 阿苯达唑砜单抗 | 5461 |
| 金刚烷胺单抗 | 5485 |
| 卡那霉素单抗 | 5662 |
| 黄曲霉毒素M1（AFM1）单抗 | 5639 |
| 群勃龙（孕三烯酮）（去甲雄三烯醇酮）单抗 | 5777 |
| 帕托珠利（妥曲珠利砜）单抗 | 5556 |
| 泰乐菌素单抗 | 5593 |
| 替米考星单抗 | 5669 |
| 新霉素单抗 | 5692 |
| 安普霉素单抗 | 5620 |
| 三聚氰胺（MEL）单抗 | 5551 |
| 双氟沙星单抗 | 5461 |
| 西地那非单抗 | 5594 |
| 阿苯达唑单抗 | 5393 |
| 醋酸甲羟孕酮（醋酸甲孕酮）单抗 | 5552 |
| 氟苯尼考单抗 | 5570 |
| 诺龙单抗 | 5678 |
| 达氟沙星单抗 | 5784 |
| 培氟沙星单抗 | 5650 |
| 庆大霉素单抗 | 5796 |